- Home
- STRO vs GLAD Comparison
STRO vs GLAD Comparison
Compare STRO & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | GLAD |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | United States |
| Employees | 131 | 65 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 395.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STRO | GLAD |
|---|---|---|
| Price | $25.64 | $18.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $26.38 | $22.33 |
| AVG Volume (30 Days) | 159.8K | ★ 215.3K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 9.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | $13.45 | $5.90 |
| P/E Ratio | ★ N/A | $11.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $16.54 |
| 52 Week High | $27.96 | $29.50 |
Technical Indicators
Market Signals| Indicator | STRO | GLAD |
|---|---|---|
| Relative Strength Index (RSI) | 64.10 | 55.68 |
| Support Level | $0.76 | $16.54 |
| Resistance Level | $27.96 | $18.94 |
| Average True Range (ATR) | 2.13 | 0.53 |
| MACD | -0.07 | 0.16 |
| Stochastic Oscillator | 90.81 | 90.15 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.